Author: Luan, Binquan; Huynh, Tien; Cheng, Xuemei; Lan, Ganhui; Wang, Hao-Ran
Title: Targeting Proteases for Treating COVID-19 Cord-id: epkjh8is Document date: 2020_10_22
ID: epkjh8is
Snippet: [Image: see text] The unprecedented pandemic of coronavirus disease 2019 (COVID-19) demands effective treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The infection of SARS-CoV-2 critically depends on diverse viral or host proteases, which mediate viral entry, viral protein maturation, as well as the pathogenesis of the viral infection. Endogenous and exogenous agents targeting for proteases have been proved to be effective toward a variety of viral infection
Document: [Image: see text] The unprecedented pandemic of coronavirus disease 2019 (COVID-19) demands effective treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The infection of SARS-CoV-2 critically depends on diverse viral or host proteases, which mediate viral entry, viral protein maturation, as well as the pathogenesis of the viral infection. Endogenous and exogenous agents targeting for proteases have been proved to be effective toward a variety of viral infections ranging from HIV to influenza virus, suggesting protease inhibitors as a promising antiviral treatment for COVID-19. In this Review, we discuss how host and viral proteases participated in the pathogenesis of COVID-19 as well as the prospects and ongoing clinical trials of protease inhibitors as treatments.
Search related documents:
Co phrase search for related documents- active site and acute lung injury: 1, 2
- active site and low molecular weight: 1, 2, 3, 4
- acute lung injury and low expression: 1, 2
- acute lung injury and low molecular weight: 1, 2, 3
- acute lung injury cause and low molecular weight: 1
- adjacent cell and low expression: 1
Co phrase search for related documents, hyperlinks ordered by date